Pharmacology, Toxicology and Pharmaceutical Science
Hodgkin Disease
100%
Adverse Event
92%
Progression Free Survival
84%
Chemotherapy
76%
Overall Survival
61%
Randomized Controlled Trial
53%
Rituximab
15%
Fluorine 18
15%
Random Effects Model
7%
Diseases
7%
Medicine and Dentistry
Positron Emission Tomography
100%
Hodgkin's Lymphoma
100%
Adverse Event
46%
Progression Free Survival
42%
Cancer
38%
Radiation Therapy
38%
Overall Survival
30%
Randomized Controlled Trial
26%
Quality of Life
26%
Rituximab
7%
Fluorine-18
7%
Treatment Modality
7%
Meta-Analysis
3%
Intention-to-Treat Analysis
3%
Random Effects Model
3%
Diseases
3%
Adriamycin Bleomycin Vinblastine Dacarbazine
3%
Tumor
3%
Treatment Option
3%
Biochemistry, Genetics and Molecular Biology
Positron Emission Tomography
100%
Progression Free Survival
42%
Overall Survival
30%
Randomized Controlled Trial
26%
Rituximab
7%
Cochrane Library
3%
Data Extraction
3%
Embase
3%
Neuroscience
Positron Emission Tomography
100%
Radiation Therapy
38%
Randomized Controlled Trial
26%
Quality of Life
26%
Fluorine-18
7%
Rituximab
7%
Meta-Analysis
3%
ABVD
3%
Immunology and Microbiology
Positron Emission Tomography
100%
Progression Free Survival
42%
Overall Survival
30%
Rituximab
7%
Cochrane Library
3%
Data Extraction
3%
Embase
3%